Status:
COMPLETED
Cognitive Behavior Therapy for Depression
Lead Sponsor:
New York State Psychiatric Institute
Collaborating Sponsors:
National Institute of Mental Health (NIMH)
Conditions:
Depression
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Psychological mindedness(PM) is a metacognitive process in which the person uses his cognitive and affective abilities to understand his thoughts, feelings, and his behaviors as they interact with his...
Detailed Description
Cognitive Behavior Therapy (CBT) is one of the most effective psychotherapy for depression. Yet, it is effective only for 40% of the depressed people who receive this treatment. Currently, there is no...
Eligibility Criteria
Inclusion
- Males or females between the ages of 18 and 65 (inclusive).
- Primary DSM-IV-TR diagnosis of major depression
- A negative urine toxicology, i.e., a urine specimen that does not test positive for the use of drugs of abuse or use of benzodiazepines.
- Ability to give informed consent.
- Fluent in English
Exclusion
- Patients who have a "lifetime" history of Schizophrenia or other current psychotic disorder, Major Depressive Disorder with Psychotic or Catatonic features, Bipolar I Affective Disorder, or Organic Mental Disease.
- DSM-V substance abuse or dependence within the past 6 months (except nicotine or caffeine).
- Active suicidal or homicidal ideation, or judged to be at serious suicide risk.
- Any unstable medical or neurological condition.
- Presently receiving psychotherapy or psychotropic medications.
- Prior History of CBT for Depression treatment failure.
- Left-handedness
Key Trial Info
Start Date :
July 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 2 2023
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT01868711
Start Date
July 1 2013
End Date
June 2 2023
Last Update
May 17 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
New York State Psychiatric Institute
New York, New York, United States, 10032